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 As our society ages, safe and minimally invasive treatment 
for the frequent occurrence of prostatic hyperplasia have been 
sought. We have performed prostatic hightemperature 
treatment for prostatic hyperplasia with the Prostalase using 
neodymium : yattriumaluminum garnet (Nd : YAG) laser 
for patients suffering from a bladder outlet obstruction 
secondary to benign prostatic hyperplasia (BPH). We used 
agars which included various densities of protein and skim 
milk as test materials to determine whether the exothermic 
mechanism of the Nd : YAG laser irradiation has an effect on 
protein molecules. By measuring the temperature inside the 
test materials and the irradiation transmissibility, we 
verified that in tissues with the same degree of color, the 
higher the protein content, the stronger the exothermic action 
of the Nd : YAG laser. In addition, in three human prostates 
obtained through pathological autopsy, the measurement of 
the protein content and the temperature inside the prostatic 
tissue in which prostatic thermal treatment had been per-
formed showed that the exothermic action of the Nd : YAG 
laser varied according to the protein content: the higher the 
protein content, the stronger was the exothermic action. The 
present findings suggest that the temperature inside prostatic
that is provided with a cooling water perfusion device so 
that the Nd : YAG irradiation is absorbed by the protein 
in the prostatic tissue to generate heat and therapy cause 
deep coagulonecrosis in the prostatic tissue. Generally, the 
effectiveness of this treatment varies depending upon the 
shape and size of the prostate and the quantity of energy 
delivered. However, even when TUBAL-T is performed at 
similar levels of energy to treat prostatic hyperplasia of 
similar size and shape, we find considerable variation in 
the effectiveness of the treatment. In the present study, to 
identify the causes of such differences, we focused on the 
point at which the Nd : YAG laser is converted from 
optical energy to thermal energy, and we investigated the 
relationship between the protein content in prostatic tissue 
and the effect of the Nd : YAG laser. We then considered 
the factors influencing changes in the protein content of 
the prostate resulting in differences in conservative 
treatment.
tissue　 reaches　 at　least　 60~65℃ with　 intissues　 with　 a　 protein
content more than 23g/100g.
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Introduction 
 In the field of urology, the occurrence of benign prostaic 
hyperplasia (BPH) is already frequent and is expected to 
continue to increase with the aging of society. Methods of 
treatment for this condition that are safe and minimally 
invasive are thus desirable. Since Majin et al'). first 
utilized local thermal stimulation of the prostate to treat 
prostatic diseases in 1980, various types of thermal devices 
have been developed. We currently use transurethral 
balloon laser thermotherapy (TUBAL-T) for BPH, in 
which a neodymium : yattriumaluminum garnet (Nd : 
YAG) laser is irradiated over 360° from a balloon probe
Specimens and methods 
1. Specimens 
A) We used coagulated agars with various densities of 
 skim milk as test materials for the effect of the Nd 
 YAG laser on protein molecules. 
B) We used the prostatic tissue from six patients obtained 
 through total prostatectomy and pathological autopsy. 
 The ages of the patients ranged from 71-82 (average 
 77.7). Of these patients, two had been given hormonal 
 therapy for more 3 months as a pre-operative treat-
 ment ; both were given chlormadinone acetate. The 
 remaining four patients had either been treated with 
 non-hormonal therapeutic agents or were given no 
 therapy (Table 1), We also used non-treated prostatic 
 tissue from three other patients obtained through 
 pathological autopsy to measure the temperature when 
 TUBAL-T was performed at our department.
Table 1. Characteristics of patients, transmissibility, protein content and the pathological diagnosis
                     Hormonal treatment Transmissibility Protein content Pathological Patient Age 
over 3 months (%) (g/100 g) diagnosis 
1 . N . T . 82 + 1.24 8.87 F 
2. Y. T. 77 + 1.45 6.3 F 
3. K. N. 75 - 1.04 14.08 G 
4. M. M. 80 - 1.25 10.31 F 
5. T. S. 81 - 0.98 18 G 
6. F . Y . 71 - 1.04 13.48 G 
                          G = glandular hyperplasia > fibromuscular hyperplasia 
                          F = fibromuscular hyperplasia > glandular hyperplasia
2. Methods 
A) Measurement of protein content in the prostatic tissue 
   The prostatic tissue was cut into thin slices of 0.5-1.0 
 g. Two ml of phosphatebuffered saline (PBS) was added 
 to the 0.5---1.0 g of tissue, and the mixture was homoge-
 nized and centrifuged for 30 minutes at 4t at 1000 rpm. 
 The protein content of the supernatant was measured 
 using the Tonaine-TP method') which was developed by 
 improving the Bradford method'), using Coomassie
A. Measurement of protein contents in prostatic tissue 
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   After supernatant was collected, protein density 
   was measurred using Tonaine-TP. 
  B. Measurement of Nd : YAG transmissibility 
     in prostatic tissue 
                    2mm 2mm 
                                            3mm
   Power Nd : YAG laser 
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(1000pm fiber) 
         3 x 2.85 x 0.9 cm acrylic cell
Fig. 1 The prostatic tissue was placed in an acrylic cell, 
and the Nd : YAG laser was output at 1W from a400um fiber. 
The measurement was performed using a powerdensito-
meter.
 Brilliant Blue G 250 (Fig. 1). 
B) Measurement of Nd : YAG laser transmissibility in the 
 prostatic tissue 
   The prostatic tissue was placed in an acrylic cell, the 
 Nd : YAG laser was output at 1 watt (W) from a 400 lam 
 fiber, and the measurement of Nd : YAG laser power 
 density was performed using a power densitometer (Fig. 
 1). 
C) Measurement of temperature 
   We measured the temperature of the specimens and 
 that inside the human prostate using a 21G needle 
 equipped with a K-thermal sensor. The temperature of 
 the human prostate was measured at the point 5 rnm 
 outside the urethra and 2 mm towards the bladder neck 
 from the center of the laser balloon. 
D) Histopathological probe 
   Six prostates were fixed in formalin, and embedded in 
 paraffin. Hematoxylin- eosin (HE)-stained specimens 
 were then prepared. The specimens were examined 
 microscopically by only one pathologist to determine 
 whether glandular hyperplasia or fibromuscular hyper-
 plasia was dominant.
Results 
1. Measurement of the temperature inside agar and its 
  transmissibility 
 The power densitometer result of the agar specimen with 
5.6 g/100 g of protein content was 0.8 mW, the transmissi-
bility of the Nd : YAG laser was 0.93%, and the cell tem-
perature inside the specimen after 5 minutes was 40.41C 
when 1W of the Nd : YAG laser was continuously irradi-
ated. Under the same conditions, the agar specimen with 
11.2 g/100 g protein content showed 0.5 mW on the power 
densitometer, the transmissibility was 0.52%, and the cell 
temperature inside the specimen was 52.51C (Fig. 2). We 
examined the colors of the two specimens using a color 
comparing meter and confirmed that they were almost the 
same.
Fig. 2. Protein contents, temperature increase and trans-
missibility of the Nd : YAG laser irradiation in coagulated 
agar specimens with various densities of protein. Fig. 4. A prostate tissue specimen from a patient showing a 
dominance of fibromuscular hyperplasia. The number and 
the size of the glandular tubes were decreased, the height of 
the secretory epithelia was lower, and the shape of the 
secretory epithelia was cubic or flat. A striking increase in 
fibromuscular tissue is seen (HE stain ; X 100).
Fig. 3. Regression curves of the protein contents in the 
prostatic tissue and Nd : YAG laser transmissibility.
A striking inverse correlation with y being-0.903 is shown, 
suggesting that protein contents influence the conversion of 
the Nd : YAG laser irradiation from optical energy to 
thermal energy.
2. Protein content in the prostatic tissue 
 The protein content of the six patients ranged from 
8.3-18 (average 12.2) g/100 g. The protein content of two 
patients previously treated with hormonal agents ranged 
from 6.3-8.87 (average 7.59) g/100 g, and that of the 
group not previously treated with hormonal agents ranged 
from 10.31-18 (average 13.97) g/100 g. The group not 
previously treated with hormonal agents demonstrated 
higher levels of protein content (Table 1). 
3. Nd : YAG laser transmissibility in the prostatic tissue 
 The Nd : YAG laser transmissibility in the prostatic 
tissue of the six patients ranged from 0.98-1.45 (average 
1.17) %. The transmissibility in the patients previously 
treated with hormonal agents was from 1.24-1.45 (aver-
age 1.34) %, and that of the group not previously treated
Fig. 5. A prostate tissue specimen with a dominance of 
glandular hyperplasia. The size of the glandular tubes has 
become bigger, with two-strata disposition of tall cylindrical 
secretory epithelia and a basal cell stratum (HE stain; X 100).
with hormonal agents ranged from 0.98-1.25 (average 
1.08) %. The Nd : YAG laser transmissibility was lower in 
the group not previously treated with hormonal agents 
(Table 1). These results showed a striking inverse correla-
tion between the protein content in the prostatic tissue and 
the effect of the Nd : YAG laser on the prostatic tissue, 
with y being - 0.903 : this inverse correlation is repre-
sented in regression curves (Fig. 3). 
4. Histopathological probe 
 Three of the six patients showed a dominance of 
fibromuscular hyperplasia, and the other three showed a 
dominance of glandular hyperplasia (Table 1). In the
Fig. 6. Highest temperature of human prostate specimens 
obtained with Nd : YAG laser irradiation.
group that showed a dominance of fibromuscular hyper-
plasia, the number and size of the glandular tubes were 
reduced, the height of the secretory epithelia was lower, 
and the shape of the secretory epithelia had become cubic 
or flat (Fig. 4). A striking increase in fibromuscular tissue 
was observed. In contrast, in the patient group showing a 
dominance of glandular hyperplasia, the size of the glandu-
lar tubes had become bigger, and the tubes consisted of 
two-strata disposition of tall cylindrical secretory epithe-
lia and a basal cell stratum (Fig. 5). The relation between 
the histopathological findings and previous hormonal 
treatment was as follows : the two patients previously 
treated with hormonal agents showed a dominance of 
fibromuscular hyperplasia, while three of the four patients 
in the group with no previous hormonal treatment showed 
a dominance of glandular hyperplasia . 
5. Measurement of the protein content in human prostatic 
  tissue 
 We inserted a laser balloon catheter into the prostatic 
tissue specimens as we do clinically and irradiated inter-
mittently for 40 minutes at 50W. The measurement of the 
protein content was performed at the points where the 
power density became the highest and at sites 5 mm from 
the right and left sides of that point before irradiating the 
Nd : YAG laser. The protein content of specimen No.1 was 
19.95-22.83 (average 20.9) g/100 g, of No.2 was 22.3--
26.6 (average 24.5 )g/100g, and of No.3 was 21.4--23.9 
(average 22.5) g/100 g. In regard to the highest tempera-
ture of these human prostatic tissue 40 minutes after this 
TUBAL-T was performed, that of specimen No.1 was 55.3 
'C, that of No.2 was 78.1° and that of No.3 was 67.71 
(Fig. 6).
Discussion 
 In today's aging society, the incidence of cases of 
dysuria caused by prostatic hyperplasia are bound to 
increase, and the number of such patients with various 
complications (such as cardiac disorders) will also in-
crease. Methods which are less invasive such as urethral 
dilatation and placement of an intraurethral stent, have 
been developed to treat patients in whom transurethral 
resection of the prostate (TUR-P) cannot be performed 
due to serious complications, and to improve the quality 
of life of the patients. The Prostalase irradiates Nd : YAG 
laser to internal region of the prostate from a flexible 
laser balloon catheter, causes necrosis and coagulation 
and, by perfusion of the inside of the balloon with cooling 
water, keeps the temperature of the prostatic urethra 
below body temperature down to a depth of several 
millimeters to protect the urethral mucosa. The purpose of 
this method is to cause a second-phase reaction in the 
human body by Nd : YAG laser irradiation, i.e., to make 
the tissue temperature 60-65°C, to induce a non-reversible 
change in the protein, and to cause necrosis to the tissue 
structure. On that point, the treatment by the Prostalase 
is different from the vaporization of visual laser ablation 
of the prostate (VLAP) and interstional laser coagulation 
(ILCP). The effective mechanism of TUBAL-T on pro-
static hyperplasia in the canine was reported by Suzuki 
et al')., and that of human prostatic hyperplasia was 
reported by Furuya et al"'). Furuya stated that TUBAL-T 
improved dysuria due to prostatic hyperplasia by inducing 
the degeneration and necrosis of smooth muscle tissue 
surrounding the urethra. This degeneration is caused by the 
high temperature. 
 The results we obtained in the present study show that in 
prostate tissue of the same color, the higher the protein 
content, the higher the temperature by the Nd : YAG laser 
and the lower the Nd : YAG laser transmissibility. These 
findings suggest that (1) protein molecules influence the 
conversion of the Nd : YAG laser irradiation from optical 
energy to thermal energy, and (2) the higher the protein 
content, the greater the exothermic action of the Nd 
YAG laser. 
 The relation between the protein content of human 
prostatic tissue and transmissibility of the Nd : YAG laser 
indicates a striking inverse correction, with an y value of 
- 0.903. Along with the results mentioned above, the 
higher the protein content, the more easily is the optical 
energy of the Nd : YAG laser converted from optical 
energy to thermal energy and the lower the Nd : YAG laser 
transmissibility is. The human prostatic protein content 
findings and the temperature measurements showed that 
the higher the protein content, the higher was the tissue 
temperature. Because the prostates were obtained through 
pathological autopsy, the heat radiation by blood flow 
was not taken into consideration : however, in approxi-
mately 25 g/100 g of the protein content, we obtained an 
ideal tissue temperature higher than the second tempera-
ture phase (6O-65`G), at which the laser influences human 
tissue. Generally speaking, tissue change caused by the 
administration of an anti-androgen agent can be seen in 
the tubular epithelia of prostatic tissue, especially 
secretory epithelia, and the major changes are the degen-
eration of tubular epithelia, and progressive changes such 
as detachment and dropping from the basal tissue stra-
tum. These changes have been observed 3-6 months after 
the start of the anti-androgen administration"). In the 
histopathological probe experiment of the present study, 
similar changes tended to be occur in the patients previ-
ously given hormonal therapeutic agents. The difference of 
the clinical effectiveness of the Nd : YAG laser irradiation 
caused by whether or not hormonal agents were previously 
administered lies in the following mechanism : in patients 
in whom an anti-androgen agent has been administered 
over a long period of time, the amount of prostatic fluid 
decrease with the reduction of the glandular components. 
As a result, since a reduction of the protein content is 
observed, this inhibits the conversion of the optical energy 
of the Nd : YAG laser to the thermal energy. The clinical 
effectiveness varies according to whether or not hormonal 
agents were previously administered, because an effective 
increase in the temperature cannot be achieved when such 
pretreatment was administered.
Conclusion 
1. The exothermic action of the Nd : YAG laser is influ-
 enced by the protein content of prostate tissue besides 
 color. The higher the protein content, the greater the 
 exothermic effect. 
2. The two patients in whom hormonal therapy had been 
 administered as a pre-operative treatment showed
 protein contents lower than those of the group who had 
 not received hormonal treatment. 
3. A clear inverse correlation was observed between the 
 protein content of the prostatic tissue and the transmis-
 sibility of the Nd : YAG laser in the prostatic tissue. 
4. The higher the protein content in the prostatic tissue, 
 the more efficiently the optical energy of the Nd : YAG 
 laser is converted to the thermal energy ; the tempera-
 ture of the prostatic tissue was high when TUBAL-T had 
 been administered.
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